Mino, Japan

Kooji Kagara

This inventor holds 7 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kooji Kagara. Retrieved from https://idiyas.com/inventor/kooji-kagara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Minoo, JP (1993)
  • Mino, JP (1996 - 2002)

Company Filing History:


Years Active: 1993-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kooji Kagara: Innovator in Pharmaceutical Manufacturing

Introduction

Kooji Kagara is a prominent inventor based in Mino, Japan. He has made significant contributions to the field of pharmaceutical manufacturing, holding a total of 7 patents. His work focuses on innovative methods that enhance the production of essential pharmaceutical compounds.

Latest Patents

One of Kooji Kagara's latest patents is a manufacturing method for producing aminopiperazine derivatives. This invention showcases his commitment to advancing pharmaceutical processes and improving the efficiency of drug production.

Career Highlights

Kooji Kagara is currently employed at Fujisawa Pharmaceutical Company, Ltd. His role at the company allows him to apply his inventive skills in a practical setting, contributing to the development of new pharmaceutical products.

Collaborations

Throughout his career, Kooji has collaborated with notable coworkers, including Nobutaka Kawai and Norio Hashimoto. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Kooji Kagara is a dedicated inventor whose work in pharmaceutical manufacturing continues to impact the industry positively. His innovative spirit and collaborative efforts with colleagues highlight his importance in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…